Assessing Imaging Outcomes in Immuno-Oncology: Current State of Patient Response Evaluation and Future Directions, New Webinar Hosted by Xtalks
TORONTO, May 9, 2018 (Newswire.com) - The past 10 years have seen a revolution in therapeutic options for oncology patients. Immune checkpoint inhibitors, chimeric antigen receptor T-cell therapy and a range of other immuno-oncology techniques designed to rally the adaptive immune system to the patient’s defense have shown extremely promising results across a wide range of indications, often with much more tolerable side-effect profiles than traditional chemotherapy or targeted therapies.
These therapies, however, present special challenges to both treating physicians and those attempting to evaluate the results of clinical trials. In particular, pseudoprogression due to both delayed response to therapy and apparent tumor growth resulting from edema secondary to therapy can confound evaluation of patients undergoing immunotherapy using standard response criteria.
In this live presentation, Ed Ashton, Ph.D., vice president of oncology imaging at BioTel Research, will review the biological basis of these confounding factors, discuss the current state of response evaluation in immunotherapy and explore future avenues for more effective and efficient determination of response to immunotherapy in oncology clinical trials.
Join this interactive and insightful webinar on Wednesday, May 23, 2018, at 11 a.m. EDT (4 p.m. BST/UK).
For more information about this complimentary event, visit Assessing Imaging Outcomes in Immuno-Oncology: Current State of Patient Response Evaluation and Future Directions.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private and academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks, visit http://xtalks.com.
For information about hosting a webinar, visit http://xtalks.com/why-host-a-webinar/.
Contact:
Nima Rajan
Tel: +1 (416) 977-6555 ext 352
Email: [email protected]
Source: Xtalks
Share:
Tags: BioTel Research, diagnostic imaging, immunotherapy, oncology clinical trials, Xtalks